We are focused on building a broad portfolio of prescription medicines that serve unmet medical needs

We are actively seeking innovative product candidates that will complement our therapeutic expertise, strengthen our portfolio, and deliver novel products to healthcare professionals and patients in Canada in a broad range of therapeutic areas, including dermatology, GI, women’s health, CNS, urology, immunology, ophthalmology, cardiology, hepatology and respiratory.

Our team is continually evaluating businesses with commercial products, proven capabilities or where synergies exist with our current product offerings for merger or acquisition opportunities. We will selectively invest in drug development programs that provide innovative technologies.

With our proven track record of success, Cipher is the ideal partner to commercialize your product in Canada.